EXOR N.V. announced today the following Corporate Calendar for 2025:

• 26 March 2025: Board of Directors Meeting for the approval of the Company’s 2024 Annual Report

• 22 May 2025: Annual General Meeting of Shareholders for the adoption of the Company’s 2024 Financial Statements

• 17 September 2025: Board of Directors Meeting for the approval of the Company’s 2025 Half-Year Financial Report

Exor announces that Noam Ohana, who has led early-stage investments at Exor, has decided to launch his own fund.

Alongside his new venture, Noam Ohana will continue to manage Exor Ventures’ €640 million portfolio for the benefit of Exor as an independent fund manager.

Exor extends its gratitude to Noam for the years of collaboration and wishes him full success in this next stage of his life as an entrepreneur and investor.

• NAV per share increased by 9% in the first half of 2024, compared to 14% of the MSCI World Index, mainly
driven by the performance of Ferrari, Philips and Lingotto Funds.

• Strong cash flow generation with dividends received from Companies and asset disposals of €1.5 billion.
Cash deployed into Companies, Investments and share buybacks amounted to €1.1 billion, maintaining a
disciplined capital allocation.

• Net debt was €3.7 billion at 30 June 2024 from €4.0 billion at 1 January 2024, with an LTV ratio of 9%.

Exor N.V. informs that the Board of Directors meeting called for the approval of the 2024 Half-Year Financial Report, originally scheduled for Wednesday 25 September 2024, has been rescheduled to Tuesday 24 September 2024.

An updated version of the Corporate Calendar is available on Exor’s website, under the 2024 Corporate Calendar section.

Exor N.V. (the “Company”) announces today its intention to continue the share buyback program announced on 13 September 2023 (the “Program”) for the remaining amount of up to € 250 million of ordinary shares to reduce Exor’s share capital in line with the announcement made on 13 September 2023.

Exor N.V. (“Exor” or the “Company”) announces that all the resolutions proposed by the Board of Directors to the Annual General Meeting of Shareholders (the “AGM”) held today in Amsterdam were approved.

The AGM adopted Exor’s 2023 annual accounts and approved a dividend distribution of €0.46 per outstanding share, for a total of approximately €100 million. The dividend will become payable on 3 June 2024 (ex-dividend date 30 May 2024) and will be paid to the shareholders of record as of 31 May 2024 (record date).

Exor N.V. (the “Company”) announces today that it will restart the share buyback program announced on 13 September 2023 (the “Program”) for the remaining amount of up to € 250 million of ordinary shares to reduce Exor’s share capital in line with the announcement made on 13 September 2023.

The Company will start on 15 April 2024 with a first tranche of purchases up to €125 million, which is expected to complete by September 2024, or earlier if the maximum amount has been reached (the "First Tranche").